Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds

Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds


Shares in Moderna Inc. dropped at least 5% as trading opened Monday after a delay in the decision to approve the COVID-19 vaccine for adolescents ages 12-17.

via DigioNews Markets

>>>MY ANOTHER SITE ONLINE MONEY FREE TECH : DROP99FAST

>>READ MORE : DIGIO NEWS

Note : I Hope My My New News Article : Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds Of DigioNews So You Trust My site you are always updated with Latest news Daily news Everyday. Only on DigioNews : Moderna shares tank after FDA delays COVID vaccine for 12- to 17-year-olds